Delivery Order SPE2DR25D2009-SPE2DR26FJ4F0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Methotrexate 2.5 mg tablets in unit dose packs of 20 tablets, with a ceiling value of $1,671.43. This is a firm fixed-price delivery order with an ultimate completion date of October 21, 2025, and represents a non-competitive set-aside contract. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Methotrexate 2.5 mg tablets in quantities of 100 units, with a ceiling value of $1,188.90. This is a firm fixed-price delivery order with an ultimate completion date of September 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Methotrexate 2.5 mg tablets in quantities of 100 units, with a ceiling value of $10,409.17. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order and is scheduled for completion by September 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Methotrexate 2.5 mg tablets in quantities of 100 units, with a ceiling value of $2,119.10. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,379,519 units of Methotrexate 2.5 mg tablets. The $1,210.26 firm fixed-price delivery order has an ultimate completion date of August 8, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $771 delivery order to Amerisourcebergen Drug Corporation for 100 tablets of 2.5 mg methotrexate. The firm fixed price order is being fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania for delivery between August 14-15, 2023. No additional details were provided regarding the original solicitation or whether this order was placed against an existing indefinite delivery/indefinite quantity contract vehicle. The Defense Logistics...
- The Defense Logistics Agency Troop Support Medical awarded a $132,100 delivery order to Amerisourcebergen Drug Corporation for 100 tablets of 2.5 mg methotrexate. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the pharmaceutical products to be delivered to a facility in Conshohocken, Pennsylvania by September 19, 2023. Amerisourcebergen will serve as the prime contractor to supply the requested prescription drugs to the Defense...
- The Defense Logistics Agency Troop Support Medical awarded a $29,840 delivery order to Amerisourcebergen Drug Corporation for 100 tablets of 2.5 mg methotrexate. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for Amerisourcebergen to provide the pharmaceutical products from its facility in Conshohocken, Pennsylvania, with delivery required between July 14-17, 2023. The pricing is firm fixed price. No subcontractors or set-aside...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 2.5 mg methotrexate tablets in 100-count packages, with a ceiling value of $1,240.16 and a period of performance through July 2, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,951.56 Firm Fixed Price Delivery Order covers the supply of 4,565,087,756 units of Methotrexate 2.5 mg Tablets in 100-count bottles, with a completion date of July 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as the primary vehicle...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ4F0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Methotrexate 2.5 mg tablets in unit dose packaging of 20s, with a ceiling value of $1,890.64 and an ultimate completion date of December 15, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. As a prime vendor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen serves as a critical supplier of pharmaceuticals and medical supplies to military and veteran healthcare systems. The Methotrexate delivery is consistent with the company's extensive portfolio of generic and brand-name medications spanning multiple therapeutic domains, supporting the Department of Defense's healthcare procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 12/11/25 |